Perrigo Newsroom

CCORF Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $42

Futu NewsNov 7 22:35

Perrigo Company: Strategic Initiatives and Market Recovery Drive Buy Rating With $42 Price Target

TipRanksNov 7 21:49

J.P. Morgan Maintains Perrigo(PRGO.US) With Buy Rating, Cuts Target Price to $38

Futu NewsOct 21 20:36

Perrigo Company (PRGO) Receives a Buy From J.P. Morgan

TipRanksOct 21 20:10

Perrigo Is Maintained at Buy by Canaccord Genuity

Dow JonesSep 30 23:35

CCORF Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $42

Futu NewsSep 30 19:33

Buy Rating and $42 Target on Perrigo: Strategic Shift and Cost-Saving Initiatives Poised to Drive Margin Expansion

TipRanksSep 30 19:11

Perrigo Analyst Ratings

BenzingaSep 24 05:50

Jefferies Downgrades Perrigo to Hold, Lowers Price Target to $30

BenzingaSep 24 05:50

Piper Sandler Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $35

Futu NewsSep 23 19:31

Perrigo Company (PRGO) Gets a Buy From Piper Sandler

TipRanksSep 23 18:48

Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma

Seeking AlphaSep 6 20:42

CCORF Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $42

Futu NewsAug 20 19:31

Analysts Have Conflicting Sentiments on These Healthcare Companies: Perrigo Company (PRGO), Cue Biopharma (CUE) and United Therapeutics (UTHR)

TipRanksAug 20 19:06

CCORF Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $42

Futu NewsAug 15 19:34

CCORF Maintains Perrigo(PRGO.US) With Buy Rating, Announces Target Price $42

Futu NewsJul 30 19:46

Perrigo's Market Advantage and Operational Upside Prompt Buy Rating

TipRanksJul 30 19:04

CCORF Maintains Perrigo(PRGO.US) With Buy Rating

Futu NewsJul 24 19:38

Piper Sandler Trims Price Target on Perrigo to $35 From $36, Maintains Overweight Rating

MT NewswiresJul 11 22:18

Piper Sandler Maintains Overweight on Perrigo, Lowers Price Target to $35

BenzingaJul 11 19:55